Abstract
Patients with cancer are at higher risk for adverse coronavirus disease 2019 (COVID-19) outcomes. Here, we studied 1,253 patients with cancer, who were diagnosed with severe acute respiratory syndrome coronavirus 2 at a tertiary referral cancer center in India. Most patients had mild disease; in our settings, recent cancer therapies did not impact COVID-19 outcomes. Advancing age, smoking history, concurrent comorbidities and palliative intent of treatment were independently associated with severe COVID-19 or death. Thus, our study provides useful insights into cancer management during the COVID-19 pandemic.
All Keywords
【초록키워드】 COVID-19, Treatment, coronavirus disease, coronavirus, severe COVID-19, COVID-19 pandemic, Cancer, India, Comorbidity, Cancer therapy, smoking, outcomes, management, death, Mild, age, Patients with cancer, Cancer center, acute respiratory syndrome, higher risk, palliative intent, diagnosed, Most patient, provide, Advancing, 【제목키워드】 COVID-19, risk factor, Patients with cancer,
【초록키워드】 COVID-19, Treatment, coronavirus disease, coronavirus, severe COVID-19, COVID-19 pandemic, Cancer, India, Comorbidity, Cancer therapy, smoking, outcomes, management, death, Mild, age, Patients with cancer, Cancer center, acute respiratory syndrome, higher risk, palliative intent, diagnosed, Most patient, provide, Advancing, 【제목키워드】 COVID-19, risk factor, Patients with cancer,